Carcinoid syndrome echocardiography or ultrasound: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Trans-thoracic echocardiography findings include thickening and retraction of immobile tricuspid valve leaflets with associated tricuspid regurgitation and immobility of the pulmonary valve cusps. Trans-esophageal echoardiography findings provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease. | |||
==Echocardiography== | ==Echocardiography== | ||
Revision as of 19:28, 10 January 2019
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome echocardiography or ultrasound |
|
Carcinoid syndrome echocardiography or ultrasound in the news |
|
Risk calculators and risk factors for Carcinoid syndrome echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Trans-thoracic echocardiography findings include thickening and retraction of immobile tricuspid valve leaflets with associated tricuspid regurgitation and immobility of the pulmonary valve cusps. Trans-esophageal echoardiography findings provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease.
Echocardiography
Transthoracic echocardiography
- It is the gold standard for diagnosis and follow-up of carcinoid heart disease.[1]
- Should be performed in all patients with carcinoid syndrome and high suspicion of carcinoid heart disease such as clinical features or raised NT-proBNP and/or 5-HIAA levels.
- Findings includes followings:
- Thickening and retraction of immobile tricuspid valve leaflets with associated tricuspid regurgitation, which is severe at the time of identification in 90 percent of patients.
- Immobility of the pulmonary valve cusps.
Transesophageal echocardiography
- TEE is primarily used intraoperatively to image the patient with carcinoid heart disease during valve replacement surgery.
- TEE may provide incremental assessment of the degree of cardiac valve involvement and the atrial septal anatomy in patients with carcinoid heart disease.
Cardiac magnetic resonance
- It can be used to evaluate the pulmonary valve, identify cardiac metastases, and assess right ventricular size and function.[2]
References
- ↑ Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK (April 1993). "Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients". Circulation. 87 (4): 1188–96. PMID 7681733.
- ↑ Bastarrika G, Cao MG, Cano D, Barba J, de Buruaga JD (2005). "Magnetic resonance imaging diagnosis of carcinoid heart disease". J Comput Assist Tomogr. 29 (6): 756–9. PMID 16272847.